| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Betz Stephen F. is a Chief Scientific Officer at Crinetics Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sale+OE | 97,483 | $32.23 | $3,141,877.09 | -49.4% | +8.8% | - | |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 5,770 | $34.20 | $197,352.96 | -2.6% | -11.0% | +3.3% | |
| Sep 10, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 1,035 | $51.50 | $53,302.50 | -1.5% | +12.3% | -30.6% | |
| Aug 26, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $53.19 | $159,570.00 | -4.1% | +5.6% | -41.8% | |
| Aug 12, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $47.68 | $143,040.00 | -4.0% | +21.1% | -42.5% | |
| Jul 25, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $53.43 | $160,290.00 | -3.8% | +9.5% | -41.9% | |
| Jul 10, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $48.55 | $145,650.00 | -3.7% | +1.8% | -37.0% | |
| Jun 25, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $45.37 | $136,110.00 | -3.6% | +12.4% | -32.2% | |
| Jun 10, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $43.86 | $131,580.00 | -3.5% | +16.1% | -26.5% | |
| May 28, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Scientific Officer | Sell | 3,000 | $47.49 | $142,470.00 | -3.3% | +13.4% | -36.2% |